DarioHealth enters $20M at-the-market equity distribution agreement with A.G.P./Alliance Global Partners

DarioHealth Corp.

Company may issue and sell up to $20M of common stock through ATM program with A.G.P./Alliance Global Partners.
Commission of 3.00% of gross proceeds; reimbursement of expenses up to $35,000 plus quarterly fees.
Proceeds to be used for commercial activities, R&D, M&A, corporate activities, repayment of debt, and working capital.
Shares offered under effective S-3 registration statement filed March 19, 2026, effective March 27, 2026.
Company has no obligation to sell any shares and may suspend or terminate the agreement at any time.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

DarioHealth Corp. entered into Sales Agreement with A.G.P./Alliance Global Partners valued at $20,000,000 (effective 2026-03-30).

Action: entry
Agreement: atm program
Counterparty: A.G.P./Alliance Global Partners
Value: $20,000,000
Effective: 2026-03-30

Exact text from the filing

On March 30, 2026, DarioHealth Corp., a Delaware corporation (the “Company”), entered into a sales agreement (the “Sales Agreement”) with A.G.P./Alliance Global Partners (the “Agent”), pursuant to which the Company may issue and sell, from time to time, up to an aggregate of $20,000,000 of shares of its common stock

View on SEC.gov

299 material agreements filed in the last 30 days. Browse all material agreements →

DarioHealth Corp. filing history →

Source: SEC EDGAR

accession 0001104659-26-036834

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.